Sept fast approaching we should hit the 144 patient target very soon we are also inline for R&D rebates this should be very substantial. DXB also have deals at the advance stage we could land another anytime this is really up to management when to accept DXB in the drivers seat here.
Ann: Preliminary Final Report, page-17
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.040(9.76%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 45.5¢ | 41.5¢ | $820.5K | 1.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34678 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 80601 | 3 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |